StockData
Immuneering Corp logo

Immuneering Corp (IMRX) income statement

IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30
$3.38−0.07 (-2.03%)

Close on Nov 20, 2026Market cap $218.90MP/E –Yield –

See a number that looks wrong?